Kolexia
Maitre Elsa
Pharmacien
Hôpital Côte de Nacre
Caen, France
50 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie à tricholeucocytes Lymphomes Tumeurs hématologiques Syndromes myéloprolifératifs Seconde tumeur primitive Rhumatisme inflammatoire des ceintures Tumeurs spléniques Maladies auto-immunes

Industries

Abbvie
2 collaboration(s)
Dernière en 2022
AstraZeneca
1 collaboration(s)
Dernière en 2021
Janssen
1 collaboration(s)
Dernière en 2022
{{person.topindus4.name}}
{{person.topindus4.tot}} collaboration(s)
Dernière en {{person.topindus4.last}}

Dernières activités

Hairy cell leukemia 2024: Update on diagnosis, risk-stratification, and treatment-Annual updates in hematological malignancies.
American journal of hematology   05 mars 2024
Atypical meningeal localization of classical hairy cell leukemia with an impressive response to rituximab and cladribine association. A case report and literature review.
EJHaem   09 janvier 2024
Untangling hairy cell leukaemia (HCL) variant and other HCL-like disorders: Diagnosis and treatment.
Journal of cellular and molecular medicine   14 décembre 2023
Hairy cell leukaemia with unusual BRAF mutations.
Journal of cellular and molecular medicine   02 août 2023
Hairy cell leukemia with isolated bone lesions.
Clinical case reports   16 mai 2023
Exportin 1-mediated nuclear/cytoplasmic trafficking controls drug sensitivity of classical Hodgkin's lymphoma.
Molecular oncology   02 février 2023
Novel targeted treatments in hairy cell leukemia and other hairy cell-like disorders.
Frontiers in oncology   22 décembre 2022
A 3-decade multicenter European experience with cladribine as upfront treatment in 384 patients with hairy cell leukemia.
Blood advances   27 juillet 2022
Hairy cell leukemia: a specific 17-gene expression signature points to new targets for therapy.
Journal of cancer research and clinical oncology   27 avril 2022
Hairy Cell Leukemia (HCL) and HCL Variant: Updates and Spotlights on Therapeutic Advances.
Current oncology reports   11 avril 2022